Literature DB >> 15365995

Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families.

Young-Kyoung Shin1, Seung-Chul Heo, Joo-Ho Shin, Sung-Hye Hong, Ja-Lok Ku, Byong-Chul Yoo, Il-Jin Kim, Jae-Gahb Park.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC), the most common hereditary colon cancer syndrome, is a dominant disorder caused by germline defects in mismatch repair (MMR) genes. Identification of MMR gene mutations can have direct clinical implications in counseling and management of HNPCC families. We screened 44 HNPCC and 97 suspected HNPCC Korean families for germline mutations in three MMR genes: MLH1, MSH2 and MSH6. We identified twelve novel mutations: nine in MLH1(c.632_633insT, c.808_811delACTT, c.845C>G, c.1625A>C, c.1730+1delG, c.1907T>C, c.1918C>T, c.2104-2A>G and c.2170T>A), two in MSH2 (c.1886A>G, c.1316_1318delCCT) and one in MSH6 (c.3488A>T). In addition, two statically significant cSNPs in MLH1: c.1128T>C ( p=0.008 in HNPCC and p=0.037 in early-onset CRC) and c.2168C>A ( p<0.001 in HNPCC). Interestingly, the most frequent mutation, c.1757_1758insC in MLH1, was a founder mutation inherited from a common Korean ancestor. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365995     DOI: 10.1002/humu.9277

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

2.  Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

Authors:  Hinke F van Thuijl; Tali Mazor; Brett E Johnson; Shaun D Fouse; Koki Aihara; Chibo Hong; Annika Malmström; Martin Hallbeck; Jan J Heimans; Jenneke J Kloezeman; Marie Stenmark-Askmalm; Martine L M Lamfers; Nobuhito Saito; Hiroyuki Aburatani; Akitake Mukasa; Mitchell S Berger; Peter Söderkvist; Barry S Taylor; Annette M Molinaro; Pieter Wesseling; Jaap C Reijneveld; Susan M Chang; Bauke Ylstra; Joseph F Costello
Journal:  Acta Neuropathol       Date:  2015-02-28       Impact factor: 17.088

3.  Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients.

Authors:  Somayeh Shahmoradi; Ali Bidmeshkipour; Ahmad Salamian; Mohammad Hasan Emami; Zahra Kazemi; Mansoor Salehi
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

4.  Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome.

Authors:  Masanobu Takahashi; Yoichi Furukawa; Hideki Shimodaira; Masato Sakayori; Takuya Moriya; Yoshihiro Moriya; Yusuke Nakamura; Chikashi Ishioka
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

5.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

6.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

7.  Some aspects of molecular diagnostics in Lynch syndrome.

Authors:  Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

8.  The mRNA level of MLH1 in peripheral blood is a biomarker for the diagnosis of hereditary nonpolyposis colorectal cancer.

Authors:  Hong Yu; Hui Li; Yongan Cui; Wei Xiao; Guihong Dai; Junxing Huang; Chaofu Wang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

9.  Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Authors:  Hui-Ling Yap; Wei-Shieng Chieng; Jasmine Rui-Chen Lim; Robert Seng-Cheong Lim; Ross Soo; Jiayi Guo; Soo-Chin Lee
Journal:  Fam Cancer       Date:  2008-08-23       Impact factor: 2.375

10.  Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers.

Authors:  Yoon Young Choi; Su-Jin Shin; Jae Eun Lee; Lisa Madlensky; Seung-Tae Lee; Ji Soo Park; Jeong-Hyeon Jo; Hyunki Kim; Daniela Nachmanson; Xiaojun Xu; Sung Hoon Noh; Jae-Ho Cheong; Olivier Harismendy
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.